During the past decade, Mental Health Research Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mental Health Research Center" #1 sponsor was "ACADIA Pharmaceuticals Inc." with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eisai Limited" with 2 trials sponsored, "Federal Stare Budgetary Scientific Institution, Mental Health Research Center" with 2 trials sponsored and "TauRx Therapeutics Ltd" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mental Health Research Center" #1 collaborator was "Federal State Budgetary Institution V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, Saint-Petersburg, Russia" with 1 trials as a collaborator, "I.M. Sechenov First Moscow State Medical University" with 1 trials as a collaborator, "Kazan State Medical University" with 1 trials as a collaborator and "RML INVEST, Torkhovsky passage 10, Tula, Russian Federation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Mental Health Research Center" are "Schizophrenia" (3 trials), "Adjunctive Treatment of Major Depressive Disorder" (2 trials), "Alzheimer's Disease" (2 trials), "Depressive Disorder, Major" (2 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Mental Health Research Center" in a lesser frequency.

Most popular intervention types in "Mental Health Research Center" are "Drug" (17 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Pimavanserin" (4 trials), "Quetiapine" (2 trials), "Quetiapine XR" (2 trials) and "Zonisamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mental Health Research Center" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mental Health Research Center". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Mental Health Research Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mental Health Research Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".